Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

17.35
-0.6850-3.80%
Volume:747.62K
Turnover:12.97M
Market Cap:6.07B
PE:-17.86
High:17.89
Open:17.87
Low:17.17
Close:18.03
52wk High:24.28
52wk Low:1.33
Shares:349.76M
Float Shares:291.15M
Volume Ratio:0.55
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:16.76
PE(LYR):-39.49

Loading ...

Revolution Medicines alleges Erasca ERAS-0015 infringes patent, misuses trade secrets

Reuters
·
Apr 27

Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015

GlobeNewswire
·
Apr 27

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

GlobeNewswire
·
Apr 23

Erasca Tightens Timeline for ERAS-0015 Phase 1 Data

TIPRANKS
·
Apr 21

Erasca Inc - Narrows Phase 1 Data Readout for Eras-0015 to No Later Than Mid-May of 2026 - SEC Filing

THOMSON REUTERS
·
Apr 21

Erasca sees ERAS-0015 Phase 1 monotherapy data by mid-May 2026

Reuters
·
Apr 21

ERAS: Promising RAS-Mutant Oncology Pipeline and China Partnership Support Buy Rating

TIPRANKS
·
Apr 14

Bar remains unchanged for Erasca after Revolution’s ‘clear win,’ says Jefferies

TIPRANKS
·
Apr 14

Erasca drops 9% to $15.54 after Revolution pancreatic cancer data

TIPRANKS
·
Apr 14

Erasca falls -10.6%

TIPRANKS
·
Apr 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM

Reuters
·
Apr 13

Erasca Chief Legal Officer Ebun Garner disposes of 80,000 shares for $1.3 million

Reuters
·
Apr 03

Analysts Conflicted on These Healthcare Names: Erasca (ERAS) and Mereo Biopharma Group Plc (MREO)

TIPRANKS
·
Mar 26

Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007

TIPRANKS
·
Mar 26

Erasca Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 18

Erasca price target raised to $25 from $24 at JPMorgan

TIPRANKS
·
Mar 18

Does Tango Therapeutics (TNGX) Trial Pact and ESOP Shelf Hint at a Pivotal Strategic Turn?

Simply Wall St.
·
Mar 17

Erasca Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 16

Erasca price target raised to $20 from $12 at Guggenheim

TIPRANKS
·
Mar 16

Mizuho Securities Remains a Buy on Erasca (ERAS)

TIPRANKS
·
Mar 15